Asymmetric synthesis of the ABC-ring system of the antitumor antibiotic MPC1001

Journal of Organic Chemistry

Volumn 74, Issue 2, 2009, Pages 513-519

  Peng, Jianbiao ^a   Clive, Derrick L J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

[CARBONYL; ACID-INDUCED CYCLIZATION; ANTITUMOR ANTIBIOTICS; ASYMMETRIC SYNTHESIS; DIKETOPIPERAZINE; ENOLATE; L PROLINES; NATURAL PRODUCTS; RING SYSTEMS; SULFUR ATOMS; TRICYCLIC COMPOUNDS;

AMIDES; CYCLIZATION; SULFUR;

ANTIBIOTICS;

ALCOHOL; AMIDE; ANTINEOPLASTIC ANTIBIOTIC; CARBAMIC ACID; CARBAMIC ACID DERIVATIVE; CARBONYL DERIVATIVE; ESTER; HYDROXYPROLINE; MPC 1001; PIPERAZINEDIONE; SULFUR; UNCLASSIFIED DRUG; FUSED HETEROCYCLIC RINGS; MPC1001; OXEPINE DERIVATIVE;

ARTICLE; CHEMICAL MODIFICATION; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; EPIMERIZATION; ESTERIFICATION; OXIDATION; STEREOCHEMISTRY; X RAY CRYSTALLOGRAPHY; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ANTIBIOTICS, ANTINEOPLASTIC; DIKETOPIPERAZINES; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; OXEPINS; STEREOISOMERISM;

EID: 60849111980     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo802344t     Document Type: Article

References (36)

1. Isolation and structure of MPC1001: (a) Tsumagari, N.; Nakai, R.; Onodera, H.; Hasegawa, A.; Rahayu, E. S.; Ando, K.; Yamashita, Y. J. Antibiot. 2004, 57, 532-534.
2. (b) Onodera, H.; Hasegawa, A.; Tsumagari, N.; Nakai, R.; Ogawa, T.; Kanda, Y. Org. Lett. 2004, 6, 4101-4104.
3. Herath, K. B.; Jayasuriya, H.; Ondeyka, J. G.; Polishook, J. D.; Bills, G. F.; Dombrowski, A. W.; Cabello, A.; Vicario, P. P.; Zweerink, H.; Guan, Z.; Singh, S. B. J. Antibiot. 2005, 58, 686-694.
4. Seya, H.; Nozawa, K.; Nakajima, S.; Kawai, K.; Udagawa, S. J. Chem. Soc., Perkin Trans. 1 1986, 109-116.
5. (a) Ooike, M.; Nozawa, K.; Kawai, K.-I. Phytochemistry 1997, 46, 123-126.
6. (b) Seya, H.; Nozawa, K.; Udagawa, S.; Nakajima, S.; Kawai, K. Chem. Pharm. Bull. 1986, 34, 2411-2416.
7. (a) Nagarajan, R.; Neuss, N.; Marsh, M. M. J. Am. Chem. Soc. 1968, 90, 6518-6519.
8. (b) Murdock, K. C. J. Med. Chem. 1974, 17, 827-835, and references quoted therein.
9. (a) Nagarajan, R.; Huckstep, L. L.; Lively, D. H.; DeLong, D. C.; Marsh, M. M.; Neuss, N. J. Am. Chem. Soc. 1968, 90, 2980-2982.
10. (b) Moncrief, J. W. J. Am. Chem. Soc. 1968, 90, 6517-6518.
11. Cosulich, D. B.; Nelson, N. R.; van den Hende, J. H. J. Am. Chem. Soc. 1968, 90, 6519-6521.
12. Hegde, V. R.; Dai, P.; Patel, M.; Das, P. R.; Puar, M. S. Tetrahedron Lett. 1997, 38, 911-914.
13. For related compounds in which the disulfide bridge has been cleaved, see:
14. (a) Chinworrungsee, M.; Kittakoop, P.; Saenboonrueng, J.; Kongsaeree, P.; Thebtaranonth, Y. J. Nat. Prod. 2006, 69, 1404-1410.
15. (b) Kirby, G. W.; Robins, D. J.; Stark, W. M. J. Chem. Res., Synop. 1986, 302-303.
16. (a) Kawahara, N.; Nakajima, S.; Yamazaki, M.; Kawai, K. Chem. Pharm. Bull. 1989, 37, 2592-2595.
17. (b) Kawahara, N.; Nozawa, K.; Yamazaki, M.; Nakajima, S.; Kawai, K. Chem. Pharm. Bull. 1990, 38, 73-78.
18. (c) Kawahara, N.; Nozawa, K.; Yamazaki, M.; Nakajima, S.; Kawai, K. Heterocycles 1990, 30, 507-515.
19. Chemokine receptor antagonist activity, ref 1c; antiviral activity, refs 4b and 5c; antibacterial activity, refs 1a, 3b, and 7; antifungal activity, ref 2; inhibition of epidermal growth factor, ref 6; inhibition of compound 48/80-induced histamine release, ref 8; antimalarial activity, ref 7; anticancer properties, ref 1.
20. Peng, J.; Clive, D. L. J. Org. Lett. 2007, 9, 2939-2941.
21. (a) Baker, G. L.; Fritschel, S. J.; Stille, J. R.; Stille, J. K. J. Org. Chem. 1981, 46, 2954-2960.
22. (b) Heindl, C.; Hubner, H.; Gmeiner, P. Tetrahedron: Asymmetry 2003, 14, 3141-3152.
23. (c) Marusawa, H.; Setoi, H.; Sawada, A.; Kuroda, A.; Seki, J.; Motoyama, Y.; Tanaka, H. Bioorg. Med. Chem. 2002, 10, 1399-1415.
24. Konradi, A. W.; Kemp, S. J.; Pedersen, S. F. J. Am. Chem. Soc. 1994, 116, 1316-1323.
25. For recent advances in the synthesis of diketopiperazines, see: Dinsmore, C. J.; Beshore, D. C. Tetrahedron 2002, 58, 3297-3312.
26. For related reagents, see, for example: Marigo, M.; Wabnitz, T. C.; Fielenbach, D.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2005, 44, 794-797.
27. Schwan, A. L.; Brillon, D.; Dufault, R. Can. J. Chem. 1994, 72, 325-333.
28. (a) Miyaura, N.; Maeda, K.; Suginome, H. J. Org. Chem. 1982, 47,
29. 2117-2120.
30. (b) Oppolzer, W.; Radinov, R. N. Helv. Chim. Acta 1992, 75, 170-173.
31. Chaloner, P. A; Langadianou, E.; Perera, S. A. R. J. Chem. Soc., Perkin Trans. 1 1991, 2731-2735.
32. (a) Use of Z-1-bromo-2-ethoxyethene/t-BuLi, which had been successful in our model study (ref 10), gave a complex mixture. We also tried a zincate complex (cf. ref 19), but this reaction was too slow at-78 °C to be useful and gave a poor yield at a higher temperature. For related observations, see:
33. (b) Keck, G. E.; Truong, A. P. Org. Lett. 2005, 7, 2149-2152.
34. Wender, P. A.; Baryza, J. L.; Bennett, C. E.; Bi, F. C.; Brenner, S. E.; Clarke, M. O.; Horan, J. C.; Kan, C.; Lacote, E.; Lippa, B.; Nell, P. G.; Turner, T. M. J. Am. Chem. Soc. 2002, 124, 13648-13649.
35. C(4)H-C(5)H is 8.0 Hz, which corresponds closely to the value (7.7 Hz) in the natural product (ref 1b). The corresponding coupling constants for the two epimers of 4 are <3 and 7.8 Hz for cis and trans C(4) and C(5) hydrogens, respectively.
36. Uemura, S.; Ohe, K. J. Chem. Soc., Perkin Trans. 1 1990, 907-910.